- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04115852
Interoceptive Nutritional Processing in Healthy Participants and Patients With Binge-Eating-Disorder (BAG-C)
January 12, 2023 updated by: Joe Simon, University of Heidelberg Medical Center
Investigating the Neural Correlates of Interoceptive Nutritional Processing Using fMRI in Healthy Participants and Patients With Binge-Eating-Disorder
Binge-Eating-Disorder (BED) is a common eating disorder characterized by recurring episodes of uncontrollable eating.
The underlying neural mechanisms are largely unknown.
However, dysfunctional hormonal satiety signaling as well as dysfunctional neural processing of food cues are discussed as possible casual factors in the development and maintenance of this disorder.
Additional research is needed to specify the exact contribution of these observations and how they interact with each other.
Accordingly, the current study plans to investigate metabolic gut-brain signaling to better understand the underlying causes of abnormal eating behavior.
To this end, 25 healthy normal weight control participants as well as 25 patients with BED will be recruited.
The responsivity of the hypothalamus (i.e., the core region of homeostatic control) and its interaction with the mesocorticolimbic reward system will be assessed by applying a single-blind, randomized, crossover design of intravenous infusion of glucose or NaCl.
This approach allows the study of gut-brain signaling to the hypothalamus and the reward system by controlling for sensory aspects of food intake (sight, smell, and taste).
The interaction between the hypothalamus and the mesocorticolimbic reward system will be investigated using an effective connectivity analysis.
FMRI with high spatial resolution and with an optimized protocol for the investigation of the hypothalamus and the mesocorticolimbic reward system will be employed.
A better understanding of the underlying psychobiological mechanisms of BED is a fundamental requirement for the development of improved prevention and treatment strategies
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
31
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Heidelberg, Germany
- University Hospital Heidelberg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The study will enroll 25 patients with BED.
Patients will be recruited from the investigator's in- and out-patient department or by public advertisement after giving their written informed consent.
Additionally, a healthy control group of 25 participants will be recruited by public advertisement.
Description
Inclusion criteria:
- patients that meet the diagnostic criteria for BED
- Over age of 18 years.
- Right-handedness.
- Normal or corrected-to-normal vision.
- No other lifetime or current medical illness that could potentially affect appetite or body weight
Exclusion criteria (for all participants):
- History of head injury or surgery
- History of neurological disorder
- Severe psychiatric comorbidity (psychosis, bipolar disorder, substance abuse)
- Smoking
- Borderline personality disorder
- Current psychotropic medication
- Inability to undergo fMRI scan (e.g. metallic implants, claustrophobia, pacemakers)
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
CON
Healthy Controls
|
functional magnetic resonance imaging
|
BED
Patients with Binge-Eating-Disorder
|
functional magnetic resonance imaging
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the neural correlates of interoceptive nutritional processing
Time Frame: 2-3 weeks
|
cross-sectional fMRI
|
2-3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2019
Primary Completion (Actual)
August 1, 2022
Study Completion (Actual)
December 1, 2022
Study Registration Dates
First Submitted
October 2, 2019
First Submitted That Met QC Criteria
October 3, 2019
First Posted (Actual)
October 4, 2019
Study Record Updates
Last Update Posted (Estimate)
January 13, 2023
Last Update Submitted That Met QC Criteria
January 12, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- S-545/2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Binge-Eating Disorder
-
University of North Carolina, Chapel HillThe Hilda & Preston Davis Foundation; Global Foundation for Eating DisordersCompletedEating Disorder | Binge-eating DisorderUnited States
-
ShireCompleted
-
Lindner Center of HOPEUniversity of CincinnatiCompleted
-
Sao Jose do Rio Preto Medical SchoolFundação de Amparo à Pesquisa do Estado de São PauloCompletedBinge-Eating Disorder | Eating Disorders | Eating Behavior | Eating Disorder | Binge Eating Disorder Associated With ObesityBrazil
-
Nova Scotia Health AuthorityCompletedBinge-Eating Disorder | Eating DisorderCanada
-
BioprojetRecruiting
-
Lindner Center of HOPEJazz PharmaceuticalsRecruiting
-
Idorsia Pharmaceuticals Ltd.Completed
-
University of ChicagoTakedaCompleted
Clinical Trials on fmri
-
Weill Medical College of Cornell UniversityMemorial Sloan Kettering Cancer CenterWithdrawnBrain TumorsUnited States
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedMagnetic Resonance Imaging | Neuronal ActivityFrance
-
Centre Hospitalier Universitaire de Saint EtienneUniversity Hospital of Saint-EtienneCompleted
-
Brighton & Sussex Medical SchoolRecruitingDepressionUnited Kingdom
-
Van Boven, Robert W., M.D.Massachusetts Institute of Technology; The Geneva FoundationUnknownTraumatic Brain Injury | Post Traumatic Stress DisorderUnited States
-
Hospices Civils de LyonUniversity of KonstanzCompleted
-
Boston VA Research Institute, Inc.Mclean Hospital; Cambridge Health Alliance; Northeastern UniversityRecruitingSchizophrenia | Treatment-resistant Schizophrenia | Auditory HallucinationUnited States